Research is a foundational cornerstone of Parkinson Canada's mandate. Your support fosters research innovation through the Parkinson Canada Research Program, which includes the Canadian Open Parkinson Network (C-OPN) initiative, governed by strong scientific leadership. The research and clinical advisory committee (RCAC) is responsible for advising the board of directors on the state of Parkinson's research, clinical care, and emerging trends relevant to the Parkinson's community. The RCAC also oversees Parkinson Canada's Research Program and recommends research funding to the board.

The RCAC is comprised of 15-18 members. It includes members of the scientific community, the clinical community, health professionals engaged in patient care and patient advocates, and a director of the Parkinson Canada board.